Home > Insider Trading > Filing (0001213900-18-010095)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513525	Adial Pharmaceuticals Inc.	ADIL	Pharmaceutical Preparations (2834)	800667150

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1718069	Iii B. William Stilley	1180 Seminole Trail, Suite 495 Charlottesville, VA 22901	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-07-31	36,800	$0.00	372,402	No	4	J	Direct
Common Stock	Acquisiton	2018-07-31	52,227	$0.00	424,629	No	4	C	Direct
Common Stock	Acquisiton	2018-07-31	80,000	$0.00	504,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	J	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Note	Disposition	2018-07-31	52,227	$0.00	52,227	$0.44
Common Stock	Warrant to purchase common stock	Acquisiton	2018-07-31	36,800	$0.00	36,800	$6.25
Common Stock	Warrant to purchase common stock	Acquisiton	2018-07-31	52,227	$0.00	52,227	$6.25
Units	Warrant to purchase units	Acquisiton	2018-07-31	36,800	$0.00	73,600	$5.00
Common Stock	Warrant to purchase common stock	Acquisiton	2018-07-31	80,000	$0.00	80,000	$6.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
36,800	2018-07-31	2023-07-31	No	4	J	Direct
89,027			No	4	C	Direct
36,800	2018-07-31	2023-07-31	No	4	J	Direct
169,027	2018-07-31	2023-07-31	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	132,141	Indirect	Owned jointly by Mr. Stilley and his wife, Anne T. Stilley

Footnotes

The 36,800 shares of common stock and warrant to purchase 36,800 shares of common stock were received by the reporting person upon consummation of the initial public offering on July 31, 2018 in accordance with a Securities Purchase Agreement dated February 22, 2018.
The 52,227 shares of common stock and a warrant to purchase 52,227 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $17,449 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering.
On July 31, 2018, Mr. Stilley purchased 80,000 units (the "Units") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering.
The warrant to purchase 36,800 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 73,600 shares.